Release Date: 30/06/11 11:58 Summary: Interview with Tim Dobson Price Sensitive: No Download Document 101.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%